Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
Q4 2025 vs. Q3 2025
How the institutions holding Cero Therapeutics Holdings, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 11 | 0 | −11 |
| Shares | 157.0K | 0 | −157.0K (−100.0%) |
| Value | $798.7K | $0 | −$798.7K (−100.0%) |
New holders (0)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
None.
Sold out (11)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Parallel Advisors, LLC | 121,000 | $615.9K |
| ARCH Venture Management, LLC | 22,389 | $114.0K |
| Susquehanna International Group, LLP | 10,244 | $52.1K |
| Tower Research Capital LLC (TRC) | 1,299 | $6.61K |
| FNY Investment Advisers, LLC | 1,050 | $5.00K |
| Citigroup Inc | 968 | $4.93K |
| SBI Securities Co., Ltd. | 18 | $92 |
| UBS Group AG | 6 | $30 |
| Jones Financial Companies LLLP | 3 | $16 |
| Bank of America Corp | 3 | $15 |
| Royal Bank of Canada | 1 | $0 |